Clinical trial
Evaluation of Efficacy and Safety of Insulin Glargine Injected by Needle-free Jet Syringe
NCT04093284 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Efficacy and Safety of Insulin Glargine Injected by Needle-free Jet Syringe
- Lead sponsor
- Nanjing First Hospital, Nanjing Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 12, 2019
- Completion date
- October 30, 2019
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.